Man Group
PBYI icon

Man Group’s Puma Biotechnology PBYI Stock Holding History

Man Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Sell
41,506
-5,869
-12% -$43K ﹤0.01% 2152
2026
Q1 		$303K Buy
47,375
+51
+0.1% +$329 ﹤0.01% 2210
2025
Q4 		$282K Buy
+47,324
New +$251K ﹤0.01% 2040
2025
Q2 		– Sell
-37,469
Closed -$111K – 2332
2025
Q1 		$111K Buy
+37,469
New +$117K ﹤0.01% 2101
2024
Q3 		– Sell
-117,665
Closed -$384K – 2145
2024
Q2 		$384K Sell
117,665
-94,017
-44% -$413K ﹤0.01% 1744
2024
Q1 		$1.12M Buy
211,682
+42,972
+25% +$231K ﹤0.01% 1503
2023
Q4 		$731K Buy
+168,710
New +$559K ﹤0.01% 1550
2023
Q1 		– Sell
-47,749
Closed -$180K – 1808
2022
Q4 		$202K Buy
47,749
+27,568
+137% +$95.1K ﹤0.01% 1768
2022
Q3 		$48K Buy
+20,181
New +$58.9K ﹤0.01% 1897
2022
Q2 		– Sell
-80,801
Closed -$201K – 1951
2022
Q1 		$233K Buy
80,801
+24,900
+45% +$64.4K ﹤0.01% 1874
2021
Q4 		$170K Buy
55,901
+33,701
+152% +$146K ﹤0.01% 1827
2021
Q3 		$156K Buy
+22,200
New +$166K ﹤0.01% 1786
2020
Q4 		– Sell
-34,134
Closed -$344K – 1912
2020
Q3 		$344K Sell
34,134
-6,200
-15% -$63.1K ﹤0.01% 1607
2020
Q2 		$421K Buy
40,334
+6,200
+18% +$64.2K ﹤0.01% 1491
2020
Q1 		$288K Sell
34,134
-16,433
-32% -$160K ﹤0.01% 1394
2019
Q4 		$442K Buy
+50,567
New +$419K ﹤0.01% 1608
2018
Q4 		– Sell
-7,860
Closed -$360K – 2067
2018
Q3 		$360K Buy
+7,860
New +$379K ﹤0.01% 1905

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's PBYI Position: Q2 2026 in Review

Man Group reduced its Puma Biotechnology (PBYI) stake by 12% in Q2 2026, selling an estimated $43K and leaving 41,506 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #2152.

Man Group first reported a position in PBYI in Q3 2018 and has held it in 17 quarters since. The position peaked at $1.12M in Q1 2024. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Man Group held 41,506 shares of Puma Biotechnology worth $337K as of Q2 2026.
  • Man Group sold 5,869 Puma Biotechnology shares in Q2 2026, an estimated $43K.
  • Puma Biotechnology made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2152 holding.
  • Man Group first reported a position in Puma Biotechnology in Q3 2018 and has held it in 17 quarters since.
  • Man Group's Puma Biotechnology position peaked at $1.12M in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.